Hyperfine
HYPR
Market cap $72.6M

1.00 USD

-0.01

0.99%

At close Oct 10, 4:00 PM EDT

1 day

-0.99%

5 days

-0.99%

1 month

0.00%

3 months

-6.54%

6 months

-2.91%

Year to date

-11.50%

1 year

-48.98%

5 years

-89.12%

About: Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Employees: 131

Healthcare Electromedical & Electrotherapeutic Apparatus

0

Funds holding %

of 6,740 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1.39% less ownership

Funds ownership: 19.37% [Q1] → 17.98% (-1.39%) [Q2]

7% less funds holding

Funds holding: 46 [Q1] → 43 (-3) [Q2]

18% less capital invested

Capital invested by funds: $10.6M [Q1] → $8.7M (-$1.9M) [Q2]

57% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 14

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for HYPR.

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about HYPR published over the past 30 days

Zacks Investment Research

HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?

Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.

HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?

Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation

GUILFORD, Conn.--(BUSINESS WIRE)--Investigators at Johns Hopkins Hospital and the University of Texas-Houston publish study using the Swoop® system for patients on ECMO support.

Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation

Zacks Investment Research

Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock

Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.

Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock

Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care

PARIS--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of interim data supporting the role portable ultra-low-field MRI can play in acute stroke workup in a hospital emergency department setting. The findings from the study, titled Interim Analysis from Single Centre Observational Study.

Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care

Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in.

Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming H.C. Wainwright 26th Annual Global Investment Conference. Members of management are scheduled to present on Monday, September 9, 2024, at 7:00 am ET. Management will also be hosting in-person meetings at the.

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call.

Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.

Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates

Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients

PHILADELPHIA--(BUSINESS WIRE)--Hyperfine presents initial data from observational clinical studies evaluating the use of portable MR brain imaging for Alzheimer's patients.

Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients

Zacks Investment Research

Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software

Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.

Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software

See News Rankings

Charts implemented using Lightweight Charts™